Healthcare

In Vitro Diagnostics Market Size to Touch US$ 125.5 billion by 2030

The global in vitro diagnostics market size is expected to be worth around US$ 125.5 billion by 2030, according to a new report by Vision Research Reports.

The global in vitro diagnostics market size was valued at US$ 85.3 billion in 2020 and is anticipated to grow at a CAGR of 5.6% during forecast period 2021 to 2030.

In Vitro Diagnostics Market (By Product: Instruments, Reagents, Services; By Technology: Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology; By Application: Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disease, Drug testing, Others; By End-use: Hospitals, Laboratories, Home Care, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38659

Growth Factor

The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

Key Players

  • Abbott
  • Danaher
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • QIAGEN
  • Quidel Corporation
  • F. Hoffmann-La Roche AG
  • Sysmex Corporation
  • Charles River Laboratories International, Inc.
  • Quest Diagnostics
  • Agilent Technologies

Market Segmentation

  • Product
    • Instruments
    • Reagents
    • Services
  • Technology
    • Immunoassay
      • Instruments
      • Reagents
      • Services
    • Hematology
      • Instruments
      • Reagents
      • Services
    • Clinical Chemistry
      • Instruments
      • Reagents
      • Services
    • Molecular Diagnostics
      • Instruments
      • Reagents
      • Services
    • Coagulation
      • Instruments
      • Reagents
      • Services
    • Microbiology
      • Instruments
      • Reagents
      • Services
    • Others
      • Instruments
      • Reagents
      • Services
  • Application
    • Infectious Disease
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune Disease
    • Drug testing
    • Others
  • End-use
    • Hospitals
    • Laboratories
    • Home Care
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Singapore
      • Australia
    • Latin America
      • Brazil
      • Argentina
      • Mexico
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38659

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global In Vitro Diagnostics Market, By Product

7.1.  In Vitro Diagnostics Market, by Product, 2021-2030

7.1.1.    Instruments

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Reagents

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global In Vitro Diagnostics Market, By Technology

8.1.  In Vitro Diagnostics Market, by Technology, 2021-2030

8.1.1.    Immunoassay

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Hematology

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Clinical Chemistry

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Molecular Diagnostics

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Coagulation

8.1.5.1.        Market Revenue and Forecast (2017-2030)

8.1.6.    Microbiology

8.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global In Vitro Diagnostics Market, By Application

9.1.  In Vitro Diagnostics Market, by Application, 2021-2030

9.1.1.    Infectious Disease

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Diabetes

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Oncology

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Cardiology

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Nephrology

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Autoimmune Disease

9.1.6.1.        Market Revenue and Forecast (2017-2030)

9.1.7.    Drug testing

9.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global In Vitro Diagnostics Market, By End-use

10.1.        In Vitro Diagnostics Market, by End-use, 2021-2030

10.1.1.  Hospitals

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Laboratories

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Home Care

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Others

10.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global In Vitro Diagnostics Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2017-2030)

11.1.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2017-2030)

11.2.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2017-2030)

11.3.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2017-2030)

11.4.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2017-2030)

11.5.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12.  Company Profiles

12.1.              Abbott

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Danaher

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              bioMérieux SA

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Bio-Rad Laboratories, Inc.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Becton, Dickinson and Company

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Siemens Healthineers AG

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              QIAGEN

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Quidel Corporation

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              F. Hoffmann-La Roche AG

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Sysmex Corporation

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Charles River Laboratories International, Inc.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38659

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button